RT Journal Article
SR Electronic
T1 Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.27.21250631
DO 10.1101/2021.01.27.21250631
A1 Perez-Nieto, Orlando R.
A1 Escarraman-Martinez, Diego
A1 Guerrero-Gutierrez, Manuel A.
A1 Zamarron-Lopez, Eder I.
A1 Mancilla-Galindo, Javier
A1 Kammar-García, Ashuin
A1 Martinez-Camacho, Miguel A.
A1 Deloya-Tomás, Ernesto
A1 Sanchez-Diaz, Jesús S.
A1 Macías-García, Luis A.
A1 Soriano-Orozco, Raúl
A1 Cruz-Sánchez, Gabriel
A1 Salmeron-Gonzalez, José D.
A1 Toledo-Rivera, Marco A.
A1 Mata-Maqueda, Ivette
A1 Morgado-Villaseñor, Luis A.
A1 Martinez-Mazariegos, Jenner J.
A1 Ramirez, Raymundo Flores
A1 Medina-Estrada, Josue L.
A1 ñamendys-Silva, Silvio A.
A1 on behalf of the APRONOX group
YR 2021
UL http://medrxiv.org/content/early/2021/01/31/2021.01.27.21250631.abstract
AB Purpose The awake prone position (PP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate the relationship between awake PP (AP) and endotracheal intubation in patients with coronavirus disease (COVID-19).Methods In this retrospective, multicentre observational study conducted between 1 May and 12 June 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with AP or awake supine positioning (AS) were included to evaluate intubation and mortality risk in AP patients through logistic regression models; multivariable adjustment, propensity score analyses, and E-values were calculated to limit confounding. A CART model with cross-validation was also built. This study was registered at https://clinicaltrials.gov/ct2/show/NCT04407468Results 827 non-intubated patients with COVID-19 in the AP (n=505) and AS (n=322) groups were included for analysis. Less patients in the AP group required endotracheal intubation (23.6% vs 40.4%) or died (20% vs 37.9%). AP was a protective factor for intubation even after multivariable adjustment (OR=0.39, 95%CI:0.28-0.56, p<0.0001, E-value=2.01), which prevailed after propensity score analysis (OR=0.32, 95%CI:0.21-0.49, p<0.0001, E-value=2.21), and mortality (adjusted OR=0.38, 95%CI:0.25-0.57, p<0.0001, E-value=1.98). The main variables associated with PP failure in AP patients were age, lower SpO2/FiO2, and management with a non-rebreather mask. In the CART model, only two variables were used: SpO2/FiO2 (F 97.7, p<0.001) and PP (X2 50.5, p<0.001), with an overall percentage of 75.2%.Conclusion PP in awake hospitalised patients with COVID-19 is associated with a lower risk of intubation and mortality.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04407468Clinical Protocols https://clinicaltrials.gov/ProvidedDocs/68/NCT04407468/Prot_000.pdf Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Health Services Research Committee of the State of Queretaro (registration number 1178/SESEQ-HGSJR/08-05-20) and all other participating centres.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data that support the findings of this study will be available from the corresponding author upon reasonable request.PPprone position/prone positioningPaO2partial arterial pressure of oxygenSpO2peripheral arterial oxygen saturationPaO2/FiO2arterial partial pressure of oxygen /fraction of inspired oxygenPaCO2arterial partial pressure of carbon dioxideRRrespiratory rateNIVnon-invasive ventilationHFNChigh-flow nasal cannulaARDSAcute respiratory distress syndromeCOVID-19coronavirus disease 2019STROBEStrengthening the Reporting of Observational studies in EpidemiologyAPawake proneASawake supineCO-RADSCOVID-19 Reporting and Data SystemIQRinterquartile rangeSDstandard deviationCARTclassification and regression treeQUESTquick, unbiased, efficient statistical treeORodds ratioCIconfidence intervalPplpleural pressureTPPTranspulmonary pressureV/Qventilation-perfusion.